Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bioagent System to Identify Bacteria, Viruses, Toxins

By HospiMedica staff writers
Posted on 05 Oct 2006
A handheld bioagent identifier is being developed to identify bacteria, viruses, and toxins.

The purpose of the Darpa handheld isothermal silver standard (HISSS) program is to develop a bioidentifier system based on next-generation nucleic acid- and protein-
detection technologies. More...
The system will consist of an instrument, which is based on advanced microelectronics technologies and specialized embedded software, and a series of consumables.

The HISSS instrument will be a handheld battery-operated device that is capable of automatically processing a sample and identifying any bacteria, viruses, and protein toxins present. The consumables will be inexpensive cartridges that contain all of the reagents and other materials needed for an assay, and will not require refrigeration or other special storage. The system will be designed for use by first responders, military personnel, and other similar personnel with a minimum of training.

Northrop Grumman Electronic Systems (Los Angeles, CA, USA) will provide more details on the bioagent identifier at the 9th International Detection Technologies Symposium, to be held November 9-10, 2006, in San Diego (CA, USA). Details of the new sample preparation schemes and assays will be provided at the symposium.



Related Links:
Northrop Grumman Electronic Systems

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Digital Radiography System (Ceiling Free)
Digix CF Series
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.